BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees

Giovanni Ponti, Tiziana Venesio, Lorena Losi, Giovanni Pellacani, Lucio Bertario, Paola Sala, Monica Pedroni, Consalvo Petti, Stefania Maffei, Liliana Varesco, Erika Lerch, Andrea Baggio, Sara Bassoli, Caterina Longo, Stefania Seidenari

Research output: Contribution to journalArticle

Abstract

The characteristics of sebaceous gland hyperplasia (SGH) consist of yellowish or skin-colored papules and nodules. Chronic sun exposure and immunosuppressed conditions are the main environmental risk factors, whereas chronological aging regulated by hormones and molecular changes are the intrinsic risk factors. We have evaluated the contribution of BRAF, K-Ras, and N-Ras mutations to the pathogenesis of SGHs in four patients belonging to three MYH-associated polyposis (MAP) pedigrees. MAP is an autosomal-recessive disease characterized by multiple colorectal adenomas and cancer. Immunohistochemistry of mismatch repair and APC proteins was performed. DNA isolated from blood lymphocytes and formalin-fixed or paraffin-embedded SGHs was PCR amplified and sequenced. In the SGH patients, we detected T1796A heterozygous substitution (V600E) in the BRAF gene. Compound biallelic germline MYH mutations (Y165C/G382D, R168H/379delC, and Y90X/delGGA464) were detected in the MAP patients. In contrast to the majority of melanocytic lesions, activating hotspot mutations in BRAF have not been involved so far in the pathogenesis of SGH. BRAF mutation is not a specific marker of melanocytic cancerogenesis, and it can also be involved in SGHs. In both melanocytic and non-melanocytic skin tumors, BRAF mutation is linked to early tumorigenesis events.

Original languageEnglish
Pages (from-to)1387-1391
Number of pages5
JournalJournal of Investigative Dermatology
Volume127
Issue number6
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Pedigree
Sebaceous Glands
Hyperplasia
Skin
Intrinsic Factor
Mutation
Lymphocytes
Sun
Paraffin
Formaldehyde
Tumors
Repair
Blood
Substitution reactions
Genes
Aging of materials
Hormones
DNA Mismatch Repair
Germ-Line Mutation
DNA

ASJC Scopus subject areas

  • Dermatology

Cite this

BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. / Ponti, Giovanni; Venesio, Tiziana; Losi, Lorena; Pellacani, Giovanni; Bertario, Lucio; Sala, Paola; Pedroni, Monica; Petti, Consalvo; Maffei, Stefania; Varesco, Liliana; Lerch, Erika; Baggio, Andrea; Bassoli, Sara; Longo, Caterina; Seidenari, Stefania.

In: Journal of Investigative Dermatology, Vol. 127, No. 6, 06.2007, p. 1387-1391.

Research output: Contribution to journalArticle

Ponti, G, Venesio, T, Losi, L, Pellacani, G, Bertario, L, Sala, P, Pedroni, M, Petti, C, Maffei, S, Varesco, L, Lerch, E, Baggio, A, Bassoli, S, Longo, C & Seidenari, S 2007, 'BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees', Journal of Investigative Dermatology, vol. 127, no. 6, pp. 1387-1391. https://doi.org/10.1038/sj.jid.5700723
Ponti, Giovanni ; Venesio, Tiziana ; Losi, Lorena ; Pellacani, Giovanni ; Bertario, Lucio ; Sala, Paola ; Pedroni, Monica ; Petti, Consalvo ; Maffei, Stefania ; Varesco, Liliana ; Lerch, Erika ; Baggio, Andrea ; Bassoli, Sara ; Longo, Caterina ; Seidenari, Stefania. / BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees. In: Journal of Investigative Dermatology. 2007 ; Vol. 127, No. 6. pp. 1387-1391.
@article{17e2e08d995841ff9b78db9a3371772e,
title = "BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees",
abstract = "The characteristics of sebaceous gland hyperplasia (SGH) consist of yellowish or skin-colored papules and nodules. Chronic sun exposure and immunosuppressed conditions are the main environmental risk factors, whereas chronological aging regulated by hormones and molecular changes are the intrinsic risk factors. We have evaluated the contribution of BRAF, K-Ras, and N-Ras mutations to the pathogenesis of SGHs in four patients belonging to three MYH-associated polyposis (MAP) pedigrees. MAP is an autosomal-recessive disease characterized by multiple colorectal adenomas and cancer. Immunohistochemistry of mismatch repair and APC proteins was performed. DNA isolated from blood lymphocytes and formalin-fixed or paraffin-embedded SGHs was PCR amplified and sequenced. In the SGH patients, we detected T1796A heterozygous substitution (V600E) in the BRAF gene. Compound biallelic germline MYH mutations (Y165C/G382D, R168H/379delC, and Y90X/delGGA464) were detected in the MAP patients. In contrast to the majority of melanocytic lesions, activating hotspot mutations in BRAF have not been involved so far in the pathogenesis of SGH. BRAF mutation is not a specific marker of melanocytic cancerogenesis, and it can also be involved in SGHs. In both melanocytic and non-melanocytic skin tumors, BRAF mutation is linked to early tumorigenesis events.",
author = "Giovanni Ponti and Tiziana Venesio and Lorena Losi and Giovanni Pellacani and Lucio Bertario and Paola Sala and Monica Pedroni and Consalvo Petti and Stefania Maffei and Liliana Varesco and Erika Lerch and Andrea Baggio and Sara Bassoli and Caterina Longo and Stefania Seidenari",
year = "2007",
month = "6",
doi = "10.1038/sj.jid.5700723",
language = "English",
volume = "127",
pages = "1387--1391",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees

AU - Ponti, Giovanni

AU - Venesio, Tiziana

AU - Losi, Lorena

AU - Pellacani, Giovanni

AU - Bertario, Lucio

AU - Sala, Paola

AU - Pedroni, Monica

AU - Petti, Consalvo

AU - Maffei, Stefania

AU - Varesco, Liliana

AU - Lerch, Erika

AU - Baggio, Andrea

AU - Bassoli, Sara

AU - Longo, Caterina

AU - Seidenari, Stefania

PY - 2007/6

Y1 - 2007/6

N2 - The characteristics of sebaceous gland hyperplasia (SGH) consist of yellowish or skin-colored papules and nodules. Chronic sun exposure and immunosuppressed conditions are the main environmental risk factors, whereas chronological aging regulated by hormones and molecular changes are the intrinsic risk factors. We have evaluated the contribution of BRAF, K-Ras, and N-Ras mutations to the pathogenesis of SGHs in four patients belonging to three MYH-associated polyposis (MAP) pedigrees. MAP is an autosomal-recessive disease characterized by multiple colorectal adenomas and cancer. Immunohistochemistry of mismatch repair and APC proteins was performed. DNA isolated from blood lymphocytes and formalin-fixed or paraffin-embedded SGHs was PCR amplified and sequenced. In the SGH patients, we detected T1796A heterozygous substitution (V600E) in the BRAF gene. Compound biallelic germline MYH mutations (Y165C/G382D, R168H/379delC, and Y90X/delGGA464) were detected in the MAP patients. In contrast to the majority of melanocytic lesions, activating hotspot mutations in BRAF have not been involved so far in the pathogenesis of SGH. BRAF mutation is not a specific marker of melanocytic cancerogenesis, and it can also be involved in SGHs. In both melanocytic and non-melanocytic skin tumors, BRAF mutation is linked to early tumorigenesis events.

AB - The characteristics of sebaceous gland hyperplasia (SGH) consist of yellowish or skin-colored papules and nodules. Chronic sun exposure and immunosuppressed conditions are the main environmental risk factors, whereas chronological aging regulated by hormones and molecular changes are the intrinsic risk factors. We have evaluated the contribution of BRAF, K-Ras, and N-Ras mutations to the pathogenesis of SGHs in four patients belonging to three MYH-associated polyposis (MAP) pedigrees. MAP is an autosomal-recessive disease characterized by multiple colorectal adenomas and cancer. Immunohistochemistry of mismatch repair and APC proteins was performed. DNA isolated from blood lymphocytes and formalin-fixed or paraffin-embedded SGHs was PCR amplified and sequenced. In the SGH patients, we detected T1796A heterozygous substitution (V600E) in the BRAF gene. Compound biallelic germline MYH mutations (Y165C/G382D, R168H/379delC, and Y90X/delGGA464) were detected in the MAP patients. In contrast to the majority of melanocytic lesions, activating hotspot mutations in BRAF have not been involved so far in the pathogenesis of SGH. BRAF mutation is not a specific marker of melanocytic cancerogenesis, and it can also be involved in SGHs. In both melanocytic and non-melanocytic skin tumors, BRAF mutation is linked to early tumorigenesis events.

UR - http://www.scopus.com/inward/record.url?scp=34248523574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248523574&partnerID=8YFLogxK

U2 - 10.1038/sj.jid.5700723

DO - 10.1038/sj.jid.5700723

M3 - Article

C2 - 17273161

AN - SCOPUS:34248523574

VL - 127

SP - 1387

EP - 1391

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -